Holen Sie sich die Stockscreener-App
0.878
12.55%
0.0979
Schlusskurs vom Vortag:
$0.7801
Offen:
$0.786
24-Stunden-Volumen:
1.31M
Relative Volume:
1.57
Marktkapitalisierung:
$74.43M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.4933
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
+9.42%
1M Leistung:
+17.00%
6M Leistung:
-50.95%
1J Leistung:
-78.27%
1-Tages-Spanne:
$0.7803
$0.9599
1-Wochen-Bereich:
$0.76
$0.9599
52-Wochen-Spanne:
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.878 | 66.13M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-05-08 | Eingeleitet | BofA Securities | Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-10-07 | Eingeleitet | BTIG Research | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
Full technical analysis of Sutro Biopharma Inc. stockMarket Trend Review & Verified Technical Signals - Newser
Chart based analysis of Sutro Biopharma Inc. trendsMarket Movers & AI Based Trade Execution Alerts - Newser
Quantitative breakdown of Sutro Biopharma Inc. recent moveQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
Real time scanner hits for Sutro Biopharma Inc. explained2025 Earnings Surprises & Verified Technical Trade Signals - Newser
Is Sutro Biopharma Inc. stock poised for growthJuly 2025 Action & Daily Profit Focused Stock Screening - Newser
Detecting support and resistance levels for Sutro Biopharma Inc.Market Growth Report & Fast Moving Stock Trade Plans - Newser
Tools to monitor Sutro Biopharma Inc. recovery probabilityStop Loss & Momentum Based Trading Signals - Newser
How to forecast Sutro Biopharma Inc. trends using time seriesQuarterly Trade Review & AI Forecast for Swing Trade Picks - Newser
Understanding Sutro Biopharma Inc.’s price movementChart Signals & Free Fast Gain Swing Trade Alerts - Newser
Visualizing Sutro Biopharma Inc. stock with heatmapsTake Profit & Risk Adjusted Buy and Sell Alerts - Newser
Volume spikes in Sutro Biopharma Inc. stock – what they meanPortfolio Return Report & High Yield Equity Trading Tips - Newser
Has Sutro Biopharma Inc. found a price floorTrade Volume Report & High Return Stock Watch Alerts - Newser
Ranking Sutro Biopharma Inc. among high performing stocks via toolsWatch List & Daily Chart Pattern Signals - Newser
Is Sutro Biopharma Inc. trending in predictive chart modelsJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
Combining price and volume data for Sutro Biopharma Inc.Recession Risk & High Return Stock Watch Alerts - Newser
Sutro Biopharma Inc. stock momentum explainedJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Strategies to average down on Sutro Biopharma Inc.2025 Dividend Review & Community Driven Trade Alerts - Newser
Pattern recognition hints at Sutro Biopharma Inc. upsideTrend Reversal & Low Volatility Stock Recommendations - Newser
What is the target price for Sutro Biopharma Inc. stockFree Growth Stock Screener - thegnnews.com
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Real time breakdown of Sutro Biopharma Inc. stock performanceFree Day Trading Signals With High Precision - Newser
Has Sutro Biopharma Inc. formed a bullish divergenceMomentum Detection with Entry Optimization - Newser
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Sutro Biopharma's Strategic Turnaround: A Path to Profitability Amidst Industry Challenges - AInvest
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase - TipRanks
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results - TipRanks
Sutro Biopharma 2025 Q2 Earnings Significant Net Loss Reduction - AInvest
Sutro Biopharma Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
SUTRO BIOPHARMA, INC. SEC 10-Q Report - TradingView
Sutro Biopharma earnings beat by $0.27, revenue topped estimates - Investing.com Canada
SUTRO BIOPHARMA Earnings Results: $STRO Reports Quarterly Earnings - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Advances Pipeline with Strategic Initiatives - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Sutro Reports 148% Revenue Growth as ADC Pipeline Expands, FDA Partnership Accelerates Development - Stock Titan
Chart overlay techniques for tracking Sutro Biopharma Inc.Low Drawdown Picks with Weekly Updates - Newser
Sutro Biopharma Inc. Inches Above Key Support — Safe to HoldConfirmed Setup With Expert Accuracy Supported - beatles.ru
Using Ichimoku Cloud for Sutro Biopharma Inc. technicalsFast Return Equity Forecast With Logic - Newser
News impact scoring models applied to Sutro Biopharma Inc.Free Daily Momentum Screener With Alerts - Newser
Sutro Biopharma Inc. stock trend outlook and recovery pathFree Reliable Investment Entry Point Signals - Newser
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sutro Biopharma Inc-Aktie (STRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
| NEWELL WILLIAM J | CEO |
Mar 04 '25 |
Option Exercise |
0.00 |
31,125 |
0 |
291,625 |
| Chung Jane | PRESIDENT AND COO |
Mar 04 '25 |
Option Exercise |
0.00 |
7,875 |
0 |
100,642 |
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):